Literature DB >> 21948256

Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance.

Kumar Vivek1, Moiz M Mustafa, Eduardo Rodriguez, Robert R Redfield, Ronald F Parsons, Susan Rostami, Thi-Sau Migone, Michael P Cancro, Ali Naji, Hooman Noorchashm.   

Abstract

Transplantation tolerance remains an elusive goal as B-cell-initiated chronic humoral rejection evades current immunosuppression. B-cell-directed therapy is thus emerging as a key component in achieving transplantation tolerance and long-term graft survival. Here, we propose strategies of B-cell repertoire remodeling to achieve humoral unresponsiveness to donor antigens with implementation of fundamental B-cell immunobiology and use of newly developed B-cell-directed agents.

Entities:  

Mesh:

Year:  2011        PMID: 21948256     DOI: 10.1007/s12026-011-8246-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  3 in total

1.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

Review 2.  Human leukocyte antigen antibodies and chronic rejection: from association to causation.

Authors:  Paul I Terasaki; Junchao Cai
Journal:  Transplantation       Date:  2008-08-15       Impact factor: 4.939

3.  Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Authors:  Nils Lachmann; Paul I Terasaki; Klemens Budde; Lutz Liefeldt; Andreas Kahl; Petra Reinke; Johann Pratschke; Birgit Rudolph; Danilo Schmidt; Abdulgabar Salama; Constanze Schönemann
Journal:  Transplantation       Date:  2009-05-27       Impact factor: 4.939

  3 in total
  2 in total

Review 1.  Biologic agents in islet transplantation.

Authors:  Boris Gala-Lopez; Andrew R Pepper; A M James Shapiro
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 2.  Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment.

Authors:  Jean L Scholz; Michael P Cancro
Journal:  Immunol Lett       Date:  2012-02-06       Impact factor: 3.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.